Wockhardt Medicines Limited, a active public limited company, was established on 25 March 2019 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U74999MH2019PLC322942. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Stephen Sabbas Dsouza (Director), Sujatha Shashikant Shetty (Director), Janet Gonsalves (Director). Past directors included Shobhana Satish Nagwekar, Sujatha Shashikant Shetty, Janet Gonsalves. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at A/501, 5Th Floor, Kanakia Zillion, Next To Kurla Bus Depot, Kurla, Mumbai, Maharashtra, 400070.
U74999MH2019PLC322942
322942
25 March 2019
₹1.00 M
₹0.50 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Wockhardt Medicines Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Stephen Sabbas Dsouza | Director | 25 Mar 2019 | Current |
| Sujatha Shashikant Shetty | Director | 30 Mar 2021 | Current |
| Janet Gonsalves | Director | 01 Jun 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Mar 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
| Pramod Abcsdd | Director | 31 May 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Wockhardt Medicines Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 202.77% decrease in profit. The company's net worth observed a substantial decline by a decrease of 201.66%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Wockhardt Medicines had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Wockhardt Medicines, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Wockhardt Medicines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wockhardt Medicines's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Wockhardt Medicines Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
Progress on Wockhardt Medicines Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
Janet Gonsalves was appointed as a Director was appointed as a Director on 01 Jun 2022 & has been associated with this company since 3 years 6 months . was recorded as a recent event.
The activity Sujatha Shashikant Shetty was appointed as a Director was appointed as a Director on 30 Mar 2021 & has been associated with this company since 4 years 8 months . was completed.
Stephen Sabbas Dsouza was appointed as a Director was appointed as a Director on 25 Mar 2019 & has been associated with this company since 6 years 8 months . was recorded as a recent event.
Wockhardt Medicines Limited was registered on 25 Mar 2019 with Roc Mumbai & aged 6 years 8 months as per MCA records. was recorded as a recent event.
The company had posted a net loss of Rs 89.18 crore in the same period a year ago. .
"I believe that the development work on these drugs today will shape the global war on Antimicrobial Resistance (AMR) tomorrow," he added..
The individual suitors have indicated that they are interested in buying at least 51% stake in a deal that could value the biz at Rs 4,000-4,500 crore..
Wockhardt's bioequivalence centre in Aurangabad, Maharashtra received zero observations from the USFDA after an inspection. This means they followed all the rules and will likely get approvals for their new drugs. #Winning #USFDA #ZeroObservations #Bioequivalence #Wockhardt.
The CIN of Wockhardt Medicines Limited is U74999MH2019PLC322942.
Wockhardt Medicines Limited is headquartered at A/501, 5Th Floor, Kanakia Zillion, Next To Kurla Bus Depot, Kurla, Mumbai, Maharashtra, 400070.
Wockhardt Medicines Limited was incorporated on 25 March 2019.
The current directors of Wockhardt Medicines Limited are
The primary industry of Wockhardt Medicines Limited is Manufacturing.
Wockhardt Medicines Limited is unlisted.
The authorized capital of Wockhardt Medicines Limited is ₹1.00 M, and the paid-up capital is ₹0.50 M.
The compliance status of Wockhardt Medicines Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX